utilities

Archive | Government and policy

Early Access Scheme

Dr Matthew Norton

The Government has announced the intention to fast-track breakthrough drugs to seriously ill patients under a new Early Access Scheme, as promised in the 2011 Life Sciences Strategy. It is aimed at innovative drugs for serious illnesses for which there is no existing treatment or where the current medicines are inadequate – like dementia. The […]

Read more

Alzheimer’s Research UK Annual Review

Lloyd VaughanKirsty MaraisKaty McIntosh

Welcome to a year at Alzheimer’s Research UK: a year that saw us become the Charity Times’ Charity of the year; a year when we have again broken records for fundraising and research investment; and a year where our scientists have made critical new discoveries on the path to defeating dementia. Below are some of […]

Dementia to remain a national priority

Lloyd VaughanKirsty MaraisKaty McIntosh

A ‘refresh’ of the National Dementia Strategy, quicker diagnosis and a World Dementia Council It’s been an exciting week for dementia. Like buses, you wait ages for exciting announcements from Government and then three come along at once! An update of the National Dementia Strategy First, on Tuesday the Secretary of State for Health Jeremy Hunt […]

‘You’re just a bit doolally’: Tackling the stigma of dementia

Dr Matthew Norton

This is a cross Blog post with the International Longevity Centre-UK Stigma is an issue that continues to blight progress in dementia research and support for people with dementia and their carers. It is mainly exhibited through fear and people who have the condition being discredited or ostracised. It often stems from wider ageism – the […]

Read more

Will this be the year that turns the corner for dementia?

Katy Riddick

The close of 2013 brought the first-ever G8 Summit on Dementia, a meeting of the world’s top economies to commit to tackling dementia jointly. The summit brought a great deal of attention to the global need for dementia research and encouraged hope for a cure. As we begin 2014 we might start to wonder: Will […]

Read more

A chance not to be missed

Lloyd VaughanKirsty MaraisKaty McIntosh

This week in London marks a pivotal moment in dementia research; it will either be considered a time of historical significance when global interests align under a banner of defeating dementia, or an instance in which a global health crisis was only superficially addressed by the world’s largest economies. The G8 Dementia Summit Heads of […]

Why is dementia research the elephant in the room?

Dr Matthew Norton

This is a cross Blog post with Age UK With the Care Bill running through parliament, the development of historic reform of the funding system for social care and much political focus on the integration with the health system. One could be forgiven for thinking that the Gordian Knot that is health and social care […]

Read more

Right drug, right patient, right time

Lloyd VaughanKirsty MaraisKaty McIntosh

This month we’ll be at the political party conferences urging all parties to continue to back dementia research. With no new drugs since 2003, and those in existence only showing modest efficacy, we desperately need new treatments that can delay the onset, slow the progression and manage the symptoms of dementia. Only through research can we make progress and offer hope to people with dementia.